← Back to Search

Herbal Medicine

Chinese herbs formula: Shu Yu Wan for Non-Small Cell Lung Cancer (CH:II Trial)

N/A
Waitlist Available
Research Sponsored by Lady Davis Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 weeks
Awards & highlights

CH:II Trial Summary

This study is evaluating whether Chinese Herb supplements lead to a measurable improvement in symptoms commonly experienced by patients with advanced stage lung cancer and an improvement in quality of life.

CH:II Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Physical Well-Being Scores at Baseline and 6 Weeks
Secondary outcome measures
Fatigue scores at Baseline and 6 weeks

CH:II Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Chinese herbs formula: Shu Yu WanExperimental Treatment1 Intervention
Participants will receive Shu Yu Wan capsules, to take 3 times daily for 6 weeks.
Group II: PlaceboPlacebo Group1 Intervention
Participants will receive capsules to take 3 times daily for 6 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Chinese herbs formula: Shu Yu Wan
2015
N/A
~20

Find a Location

Who is running the clinical trial?

Lady Davis InstituteLead Sponsor
44 Previous Clinical Trials
5,520 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025